Deploy a report





Chart - Bermuda - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Chart - Bermuda - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Table - Bermuda - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Date
Export Countries
2020 2021 2022 2023 2024
United States 1.070.278 3.090.068 571.988 63.625 78.184
Ireland 1.413.892
France 154.200 135.413 101.335 76.093 70.081
Germany 104.935 149.708 118.289 3.731 3.227
China 32.300 304.125 3.434
Belgium 64.331 25.931 53.508 87.315 18.522
South Korea 31.000 2.000 47.000 42.000 50.000
United Kingdom 53.938
Italy 16.297 7.684 12.471 14.148
Netherlands 284 10.361 4.385 18.564
Others 335 922 2.080 1.805 1.152
Total 1,527,899 3,715,852 917,032 1,706,993 243,165

Chart - Bermuda - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Chart - Bermuda - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Table - Bermuda - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Date
Export Countries
03 - 2025 04 - 2025 05 - 2025 06 - 2025 07 - 2025
United States 10.230 10.124 11.482 10.997 28.396
France 26.307 928
China 9.905 15.628
Belgium 10.311 2.299
Netherlands 3.752 8.110
Germany 2.219
Total 13,982 10,124 48,100 23,201 55,281

Chart - Bermuda - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Chart - Bermuda - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Table - Bermuda - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Date
Import Countries
2021 2022 2023 2024
Uruguay 1.950.298 18.603.283
South Korea 15.000
France 224 420
Ireland 51
Denmark 28
Total 224 80 1,950,298 18,618,703

Chart - Bermuda - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Chart - Bermuda - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Table - Bermuda - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Date
Import Countries
03 - 2025 04 - 2025 05 - 2025 06 - 2025 07 - 2025
Uruguay 7.558.085 6.460.147 54.849 8.817.042 10.344.953
Total 7,558,085 6,460,147 54,849 8,817,042 10,344,953

Chart - Bermuda - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Chart - Bermuda - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Table - Bermuda - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Date
Export Countries
2020 2021 2022 2023 2024
Importaciones
United States 1.070.278 3.090.068 571.988 63.625 78.184
Ireland 1.413.892
France 154.200 135.413 101.335 76.093 70.081
Germany 104.935 149.708 118.289 3.731 3.227
China 32.300 304.125 3.434
Belgium 64.331 25.931 53.508 87.315 18.522
South Korea 31.000 2.000 47.000 42.000 50.000
United Kingdom 53.938
Italy 16.297 7.684 12.471 14.148
Netherlands 284 10.361 4.385 18.564
Others 335 922 2.080 1.805 1.152
Total 1,527,899 3,715,852 917,032 1,706,993 243,165

Date
Import Countries
2021 2022 2023 2024
Exportaciones
Uruguay 1.950.298 18.603.283
South Korea 15.000
France 224 420
Ireland 51
Denmark 28
Total 224 80 1,950,298 18,618,703

Chart - Bermuda - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Chart - Bermuda - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Table - Bermuda - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Date
Export Countries
03 - 2025 04 - 2025 05 - 2025 06 - 2025 07 - 2025
Importaciones
United States 10.230 10.124 11.482 10.997 28.396
France 26.307 928
China 9.905 15.628
Belgium 10.311 2.299
Netherlands 3.752 8.110
Germany 2.219
Total 13,982 10,124 48,100 23,201 55,281

Date
Import Countries
03 - 2025 04 - 2025 05 - 2025 06 - 2025 07 - 2025
Exportaciones
Uruguay 7.558.085 6.460.147 54.849 8.817.042 10.344.953
Total 7,558,085 6,460,147 54,849 8,817,042 10,344,953